Shrimp Disease Management: EMS, White Spot, and the Welfare Cost of Antibiotic Overuse

Disease outbreaks are the primary welfare and economic challenge in shrimp aquaculture. Management approaches significantly affect both individual shrimp welfare and public health.

Key Facts

Early Mortality Syndrome (EMS/AHPND) and White Spot Syndrome Virus (WSSV) cause mass mortality events in shrimp farms, with losses reaching 40–80% of stocked populations.
Disease outbreaks kill billions of shrimp annually through rapid physiological failure — a welfare event at extraordinary scale even if individual shrimp sentience remains uncertain.
Antibiotic use in shrimp farming — particularly in Asia — is widespread and often prophylactic, contributing to antimicrobial resistance in human pathogens.
Probiotics, biosecurity improvements, and selective breeding for disease resistance are reducing antibiotic dependency in progressive operations.
Overcrowding and poor water quality are primary disease risk factors; welfare improvements that reduce stocking density and improve water management simultaneously improve disease outcomes.
Vaccination against specific pathogens is limited in shrimp because their immune system lacks adaptive immunity; biosecurity and genetic resistance are primary prevention tools.

Welfare Considerations

Shrimp disease outbreaks cause mass death at scales that dwarf most other animal welfare events, even under conservative assumptions about shrimp sentience. The physiological distress of disease — immune activation, organ failure, behavioural changes — occurs across populations of hundreds of millions in single outbreak events. Antibiotic overuse to suppress disease creates resistance that then affects human medicine, demonstrating that poor animal welfare and public health risks are intertwined. The disease-welfare link is direct: overcrowded, stressed shrimp are immunosuppressed shrimp that succumb to pathogens faster, creating a cycle where poor welfare drives disease and disease creates further welfare harm. Improving conditions reduces both welfare costs and disease risk simultaneously.

What You Can Do

Choose shrimp from ASC-certified farms that require responsible antibiotic use and disease management protocols.
Support research into shrimp genetics programmes developing disease-resistant lines that reduce antibiotic dependency.
Advocate for mandatory antibiotic use reporting in shrimp aquaculture as a precondition for market access in the EU and US.
Reduce consumption of uncertified farmed shrimp from high-risk production regions with poor disease management practices.
Support the Shrimp Welfare Project's research into the relationship between disease management and individual shrimp welfare.